Items related to The Evaluation of Beat Blocker and Calcium Antagonist...
The Evaluation of Beat Blocker and Calcium Antagonist Drugs: 18 (Developments in Cardiovascular Medicine, 18) - Softcover
With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States.
"synopsis" may belong to another edition of this title.
- PublisherSpringer
- Publication date2011
- ISBN 10 9400975635
- ISBN 13 9789400975637
- BindingPaperback
- Number of pages419
- EditorMorganroth J., Moore E. Neil
Top Search Results from the AbeBooks Marketplace
Seller Image
The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Developments in Cardiovascular Medicine) (Volume 18) [Soft Cover ]
Seller:
Rating
Book Description Soft Cover. Condition: new. Seller Inventory # 9789400975637
Buy New
£ 50.36
Convert currency
Stock Image
The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Developments in Cardiovascular Medicine, 18)
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Apr0412070052947
Buy New
£ 49.72
Convert currency
Stock Image
The Evaluation of Beat Blocker and Calcium Antagonist Drugs
Published by
Springer
(2011)
ISBN 10: 9400975635
ISBN 13: 9789400975637
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9789400975637_lsuk
Buy New
£ 50.20
Convert currency
Stock Image
The Evaluation of Beat Blocker and Calcium Antagonist Drugs
Published by
Martinus Nijhoff Publisher
(2013)
ISBN 10: 9400975635
ISBN 13: 9789400975637
New
Paperback
Quantity: 2
Seller:
Rating
Book Description Paperback. Condition: Brand New. 424 pages. 9.25x6.10x0.96 inches. In Stock. Seller Inventory # x-9400975635
Buy New
£ 60.67
Convert currency
Seller Image
The Evaluation of Beat Blocker and Calcium Antagonist Drugs
Published by
Springer Netherlands
(2011)
ISBN 10: 9400975635
ISBN 13: 9789400975637
New
Taschenbuch
Quantity: 1
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States. Seller Inventory # 9789400975637
Buy New
£ 52.79
Convert currency
Seller Image
The Evaluation of Beat Blocker and Calcium Antagonist Drugs
Published by
Springer Netherlands
(2011)
ISBN 10: 9400975635
ISBN 13: 9789400975637
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. With the beginning of the 1980 s it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring . Seller Inventory # 5829282
Buy New
£ 42.91
Convert currency
Stock Image
The Evaluation of Beat Blocker and Calcium Antagonist Drugs
Seller:
Rating
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9789400975637
Buy New
£ 71.66
Convert currency
Seller Image
The Evaluation of Beat Blocker and Calcium Antagonist Drugs
Published by
Springer Netherlands Nov 2011
(2011)
ISBN 10: 9400975635
ISBN 13: 9789400975637
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States. 424 pp. Englisch. Seller Inventory # 9789400975637
Buy New
£ 75.89
Convert currency